Authors/Disclosures
|
Suresh Subramaniam, MD
(Department of Clinical Neurosciences)
|
No disclosure on file |
|
Asaff Harel, MD
|
Dr. Harel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute. |
|
Andrew M. Demchuk, MD
(Foothills Hospital/Calgary Stroke Program)
|
Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lumosa. Dr. Demchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer/BMS. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Demchuk has received stock or an ownership interest from Circle NVI. Dr. Demchuk has received intellectual property interests from a discovery or technology relating to health care. |
|
Leila Montaser-Kouhsari, MD, PhD
(Stanford University)
|
Dr. Montaser-Khousari has received personal compensation in the range of $0-$499 for serving as a Consultant for Darmyian, Trinity Life Sciences, Guidepoint and Techspert. Dr. Montaser-Khousari has received research support from DoD. |
|
Tim W. Watson, MD
(Island Neurology)
|
No disclosure on file |
|
|
No disclosure on file |
|
Ling Pan, MD
(Rutgers Health)
|
No disclosure on file |
|
Michael D. Hill, MD
(University of Calgary)
|
Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular. |
|
Michelle Fabian, MD, FAAN
(Mount Sinai Hospital)
|
Dr. Fabian has nothing to disclose. |
|
Sylvia Klineova, MD
(Icahn School of Medicine At Mount Sinai)
|
Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Klineova has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. |
|
|
No disclosure on file |